Reuters logo
BRIEF-Respira Therapeutics says entered into strategic collaboration with United Therapeutics
April 12, 2017 / 2:51 PM / 5 months ago

BRIEF-Respira Therapeutics says entered into strategic collaboration with United Therapeutics

April 12 (Reuters) - Respira Therapeutics

* Respira Therapeutics says entered into a strategic collaboration with united therapeutics corporation for development and exclusive license of respira’s rt234

* In addition, United Therapeutics will be lead investor in respira’s series B preferred stock financing

* As per collaboration, United Therapeutics will provide co with non-dilutive development funding to advance rt234 through fda approval

* Additional terms of strategic collaboration were not disclosed

* To continue advancing development of other pipeline programs,to retain full control of research and development programs outside of pulmonary hypertension Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below